John Ransom
Stock Analyst at Raymond James
(4.60)
# 247
Out of 5,036 analysts
212
Total ratings
65.97%
Success rate
16.25%
Average return
Main Sectors:
Stocks Rated by John Ransom
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
ACHC Acadia Healthcare Company | Maintains: Outperform | $26 → $30 | $23.84 | +25.84% | 10 | Oct 3, 2025 | |
RDNT RadNet | Reiterates: Strong Buy | $66 → $75 | $79.10 | -5.18% | 12 | Aug 13, 2025 | |
AVAH Aveanna Healthcare Holdings | Upgrades: Outperform | $9 | $10.24 | -12.11% | 8 | Aug 11, 2025 | |
SCI Service Corporation International | Reiterates: Outperform | $85 → $90 | $83.48 | +7.81% | 13 | Aug 4, 2025 | |
THC Tenet Healthcare | Reiterates: Outperform | $185 → $200 | $202.10 | -1.04% | 18 | Jul 23, 2025 | |
CI The Cigna Group | Maintains: Strong Buy | $360 → $385 | $308.19 | +24.92% | 18 | May 5, 2025 | |
UNH UnitedHealth Group | Reiterates: Strong Buy | $635 → $540 | $369.92 | +45.98% | 13 | Apr 21, 2025 | |
HCA HCA Healthcare | Downgrades: Market Perform | n/a | $430.86 | - | 21 | Nov 22, 2024 | |
CYH Community Health Systems | Downgrades: Underperform | n/a | $3.17 | - | 8 | Nov 22, 2024 | |
GDRX GoodRx Holdings | Upgrades: Outperform | $10 | $3.94 | +153.81% | 2 | May 16, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Strong Buy | $85 → $95 | $124.57 | -23.74% | 15 | Apr 26, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $294.15 | - | 1 | Mar 22, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $20 | $21.47 | -6.85% | 1 | Mar 22, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $25 → $30 | $23.27 | +28.92% | 12 | Mar 15, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Strong Buy | $10 → $12 | $17.55 | -31.62% | 9 | Jan 9, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $90 → $85 | $83.08 | +2.31% | 7 | Aug 4, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $100 → $105 | $121.14 | -13.32% | 8 | Aug 2, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $8 → $10 | $9.78 | +2.25% | 4 | Aug 1, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $3.13 | - | 11 | May 10, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $28.02 | - | 7 | May 3, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $44.20 | - | 2 | Feb 14, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $26.78 | - | 2 | Dec 20, 2019 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $128.69 | - | 8 | Nov 7, 2019 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $20.95 | - | 2 | Aug 9, 2017 |
Acadia Healthcare Company
Oct 3, 2025
Maintains: Outperform
Price Target: $26 → $30
Current: $23.84
Upside: +25.84%
RadNet
Aug 13, 2025
Reiterates: Strong Buy
Price Target: $66 → $75
Current: $79.10
Upside: -5.18%
Aveanna Healthcare Holdings
Aug 11, 2025
Upgrades: Outperform
Price Target: $9
Current: $10.24
Upside: -12.11%
Service Corporation International
Aug 4, 2025
Reiterates: Outperform
Price Target: $85 → $90
Current: $83.48
Upside: +7.81%
Tenet Healthcare
Jul 23, 2025
Reiterates: Outperform
Price Target: $185 → $200
Current: $202.10
Upside: -1.04%
The Cigna Group
May 5, 2025
Maintains: Strong Buy
Price Target: $360 → $385
Current: $308.19
Upside: +24.92%
UnitedHealth Group
Apr 21, 2025
Reiterates: Strong Buy
Price Target: $635 → $540
Current: $369.92
Upside: +45.98%
HCA Healthcare
Nov 22, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $430.86
Upside: -
Community Health Systems
Nov 22, 2024
Downgrades: Underperform
Price Target: n/a
Current: $3.17
Upside: -
GoodRx Holdings
May 16, 2024
Upgrades: Outperform
Price Target: $10
Current: $3.94
Upside: +153.81%
Apr 26, 2024
Reiterates: Strong Buy
Price Target: $85 → $95
Current: $124.57
Upside: -23.74%
Mar 22, 2024
Initiates: Market Perform
Price Target: n/a
Current: $294.15
Upside: -
Mar 22, 2024
Initiates: Outperform
Price Target: $20
Current: $21.47
Upside: -6.85%
Mar 15, 2024
Reiterates: Outperform
Price Target: $25 → $30
Current: $23.27
Upside: +28.92%
Jan 9, 2024
Maintains: Strong Buy
Price Target: $10 → $12
Current: $17.55
Upside: -31.62%
Aug 4, 2023
Maintains: Outperform
Price Target: $90 → $85
Current: $83.08
Upside: +2.31%
Aug 2, 2023
Maintains: Outperform
Price Target: $100 → $105
Current: $121.14
Upside: -13.32%
Aug 1, 2023
Maintains: Outperform
Price Target: $8 → $10
Current: $9.78
Upside: +2.25%
May 10, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $3.13
Upside: -
May 3, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $28.02
Upside: -
Feb 14, 2020
Downgrades: Market Perform
Price Target: n/a
Current: $44.20
Upside: -
Dec 20, 2019
Initiates: Market Perform
Price Target: n/a
Current: $26.78
Upside: -
Nov 7, 2019
Downgrades: Market Perform
Price Target: n/a
Current: $128.69
Upside: -
Aug 9, 2017
Downgrades: Market Perform
Price Target: n/a
Current: $20.95
Upside: -